373 related articles for article (PubMed ID: 35381274)
1. Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers.
Song M; Dong S; An X; Zhang W; Shen N; Li Y; Guo C; Liu C; Li X; Chen S
J Control Release; 2022 May; 345():744-754. PubMed ID: 35381274
[TBL] [Abstract][Full Text] [Related]
2. Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein.
Chen H; Sha H; Zhang L; Qian H; Chen F; Ding N; Ji L; Zhu A; Xu Q; Meng F; Yu L; Zhou Y; Liu B
Int J Nanomedicine; 2018; 13():5347-5359. PubMed ID: 30254439
[TBL] [Abstract][Full Text] [Related]
3. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
4. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
5. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application.
Xia Q; Zhang Y; Li Z; Hou X; Feng N
Acta Pharm Sin B; 2019 Jul; 9(4):675-689. PubMed ID: 31384529
[TBL] [Abstract][Full Text] [Related]
6. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
[TBL] [Abstract][Full Text] [Related]
7. A novel multi-functionalized multicellular nanodelivery system for non-small cell lung cancer photochemotherapy.
Zhang Y; Xia Q; Wu T; He Z; Li Y; Li Z; Hou X; He Y; Ruan S; Wang Z; Sun J; Feng N
J Nanobiotechnology; 2021 Aug; 19(1):245. PubMed ID: 34391438
[TBL] [Abstract][Full Text] [Related]
8. Cancer cell membrane-coated biomimetic platform for targeted therapy of breast cancer in an orthotopic mouse model.
Han L; Xu Y; Guo X; Yuan C; Mu D; Xiao Y
J Biomater Sci Polym Ed; 2020 Aug; 31(12):1538-1551. PubMed ID: 32362234
[TBL] [Abstract][Full Text] [Related]
9. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
11. Co-Delivery of Curcumin and Paclitaxel by "Core-Shell" Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer.
Zhao MD; Li JQ; Chen FY; Dong W; Wen LJ; Fei WD; Zhang X; Yang PL; Zhang XM; Zheng CH
Int J Nanomedicine; 2019; 14():9453-9467. PubMed ID: 31819443
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J
Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342
[TBL] [Abstract][Full Text] [Related]
14. TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Deliver Cisplatin and Paclitaxel Prodrugs for Effective Cervical Cancer Therapy.
Jiang G; Wang X; Zhou Y; Zou C; Wang L; Wang W; Zhang D; Xu H; Li J; Li F; Luo D; Ma X; Ma D; Tan S; Wei R; Xi L
Int J Nanomedicine; 2021; 16():4087-4104. PubMed ID: 34163161
[TBL] [Abstract][Full Text] [Related]
15. Light/pH-Triggered Biomimetic Red Blood Cell Membranes Camouflaged Small Molecular Drug Assemblies for Imaging-Guided Combinational Chemo-Photothermal Therapy.
Ye S; Wang F; Fan Z; Zhu Q; Tian H; Zhang Y; Jiang B; Hou Z; Li Y; Su G
ACS Appl Mater Interfaces; 2019 May; 11(17):15262-15275. PubMed ID: 30964624
[TBL] [Abstract][Full Text] [Related]
16. Spatiotemporally sequential delivery of biomimetic liposomes potentiates glioma chemotherapy.
Zhou M; Wu Y; Sun M; Qin Y; Zhao J; Qiu Z; Li C; Zhang Y; Xiong Y; Shen Y; Zou Z; Tu J; Shen W; Sun C
J Control Release; 2024 Jan; 365():876-888. PubMed ID: 38030082
[TBL] [Abstract][Full Text] [Related]
17. Tumor Microenvironment Responsive Shape-Reversal Self-Targeting Virus-Inspired Nanodrug for Imaging-Guided Near-Infrared-II Photothermal Chemotherapy.
Li Y; Lin J; Wang P; Luo Q; Lin H; Zhang Y; Hou Z; Liu J; Liu X
ACS Nano; 2019 Nov; 13(11):12912-12928. PubMed ID: 31651142
[TBL] [Abstract][Full Text] [Related]
18. Construction of paclitaxel-loaded poly (2-hydroxyethyl methacrylate)-g-poly (lactide)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine copolymer nanoparticle delivery system and evaluation of its anticancer activity.
Ma X; Wang H; Jin S; Wu Y; Liang XJ
Int J Nanomedicine; 2012; 7():1313-28. PubMed ID: 22419875
[TBL] [Abstract][Full Text] [Related]
19. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Guo X; Chen D
Int J Pharm; 2015 Mar; 480(1-2):116-27. PubMed ID: 25615984
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted delivery of paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticles.
Kim JH; Kim Y; Bae KH; Park TG; Lee JH; Park K
Mol Pharm; 2015 Apr; 12(4):1230-41. PubMed ID: 25686010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
